Church & Dwight Co., Inc. (CHD)

NYSE: CHD · USD

$105

-0.37 (-0.3%)· Recorded snapshot

Engelse bronNL

Engelse bron wordt weergegeven terwijl we vertalen

Dit rapport is nog niet vertaald. Vernieuw over een paar minuten zodra de vertaalwachtrij is bijgewerkt.

StockMarketAgent Research · Analyzed 2026-10-08

Our latest published analysis: CHD rated Reduce

Church & Dwight Co., Inc.'s published Reduce conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.

Fair value

$80.3 / share

Potential value

$88.7 / share

Upside to FV

-18.0%

from $105

Moat

7.5/10

Narrow

Read full analysis →View archive · 24mo

9-phase methodology · same model in each published edition

Market cap	$23.2B
Revenue (ttm)	6.2B
Net income (ttm)	744.8M
EPS (ttm)	$3.11
Shares out	237.2M
P/E (trailing)	33.6x
P/E (forward)	23.4x
Dividend	$1.23 (1.17%)
Volume	1,114,784
Beta	0.48

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 6.2B
Net income (ttm): 744.8M
EPS (ttm): $3.11
P/E (trailing): 33.6x
P/E (forward): 23.4x
Market cap: $23.2B

Item	P1	P2	P3	P4	P5	Trend
Period	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31	Trend
Revenue	$5.19B	$5.38B	$5.87B	$6.11B	$6.20B	+4.6%
Gross profit	$2.26B	$2.25B	$2.59B	$2.79B	$2.77B	+5.2%
Operating income	$1.08B	$597.8M	$1.06B	$807.1M	$1.08B	-0.0%
Net income	$827.5M	$413.9M	$755.6M	$585.3M	$736.8M	-2.9%
EPS (diluted)	$3.32	$1.68	$3.05	$2.37	$3.02	-2.3%
EBITDA	$1.31B	$831.9M	$1.06B	$1.09B	$1.30B	-0.1%
R&D	$105.2M	$110.0M	$122.4M	$139.7M	$145.6M	+8.5%
SG&A	$606.7M	$706.0M	$889.8M	$927.8M	$988.3M	+13.0%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ABBV	AbbVie Inc.	505.6B	80.8x	7.9x	17.7%	+3.7%	+29.1%	Verkopen
ABT	Abbott Laboratories	177.6B	38.2x	3.7x	7.2%	+2.7%	-17.2%	Verminderen
ACN	Accenture plc	144.3B	18.0x	2.0x	27.9%	+8.0%	+0.4%	Aanhouden
ADM	Archer-Daniels-Midland Company	37.3B	21.2x	0.5x	5.0%	+1.8%	+28.5%	Verminderen
BF.B	Brown-Forman Corporation Class B	12.7B	17.9x	3.3x	14.3%	+1.6%	+0.4%	Kopen
CAG	Conagra Brands, Inc.	6.6B	—	0.6x	9.2%	+0.2%	-18.9%	Sterk kopen

Base and Bull scenarios

Base60%

Price target

$80.30

-18.0% from spot

The Base scenario reflects the modal operating trajectory. Consumer Domestic anchors consolidated revenue with steady volume compounding in specialty personal care offsetting flattish volume trends in mature laundry categories. Management achieves guided gross margin expansion through continuous productivity and trade optimization, while holding brand marketing at guided levels relative to sales to defend shelf space against scale peer affordability campaigns. Cash flow conversion remains robust, supporting modest annual dividend increases and disciplined bolt-on acquisitions.

Consolidated revenue growth tracks company guidance and consensus projections from FY2026 into FY2027
Consumer Domestic delivers steady performance with TheraBreath and Hero offsetting mature fabric care drag
Adjusted gross margin expands in line with full-year guidance, supported by manufacturing productivity
Brand marketing spend is sustained at guided levels as a percentage of sales to preserve competitive positioning against CL and PG
Operating margins normalize in FY2026 and expand gradually over the long-term horizon
Capital expenditures remain disciplined relative to revenue in FY2026, generating strong annual operating cash flow

Bull20%

Price target

$88.70

-9.4% from spot

Under the Bull scenario, international consumer distribution expands rapidly across Europe and Latin America, while domestic market share gains in TheraBreath and Hero accelerate as household penetration closes the gap toward broader category averages. Manufacturing productivity programs and trade optimization deliver gross margin expansion surpassing guidance, lifting operating margins beyond historical averages and driving superior free cash flow compounding.

International consumer sales sustain high single-digit volume expansion across European and Latin American markets
TheraBreath household penetration expands significantly toward broader oral care category benchmarks
Full-year adjusted gross margin expansion exceeds management guidance through sustained productivity and favorable product mix
Operating margins expand meaningfully as SG&A leverage offsets brand reinvestment spend

Sensitivity: Ke × terminal growth

The highlighted cell is Fair value when every assumption sits at its base level ($80.30). Each row and column shows what Fair value becomes when one assumption moves.

Ke ↓ / g →	2.0%	2.3%	2.5%	2.8%	3.0%
6.7%	$88.1	$91.2	$94.6	$98.5	$103
7.2%	$81.6	$84.0	$86.7	$89.7	$93.1
7.7%	$76.2	$78.2	$80.3	$82.7	$85.3
8.2%	$71.7	$73.3	$75.0	$76.9	$79.1
8.7%	$67.8	$69.1	$70.6	$72.2	$73.9

Scorecard

Published factor rows and weighted composite

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E23.4

P25 n/aP50 n/aP75 n/a

Trailing P/E30.9

P25 n/aP50 n/aP75 n/a

ROE17

P25 n/aP50 n/aP75 n/a

ROIC14

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CHD indicators

Market & fundamental data

Available fields

290

Groups with data

Currency

USD

Showing 290 of 290 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000313927
Company name	Church & Dwight Co., Inc.
Country	United States
Country code	US
CUSIP number	171340102
Earnings date	2026-10-30
Earnings time	bmo
Employees	5,550
Employees change	-200
Employees growth	-3.48%
Enterprise value	$27B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1846
In index	SP500
Industry	Household & Personal Products
Is primary listing	Yes
Is SPAC	No
ISIN number	US1713401024
Last 10-K release date	2026-02-12
Last earnings date	2026-07-31
Last refreshed	2026-10-28
Last stock split date	2016-09-02
Last stock split type	Forward
Market cap	$24.8B
Market cap category	Large-Cap
Next earnings date	2026-10-30
Options	Yes
Price	$104.64
Price currency	USD
Sector	Consumer Staples
SIC code	2840
Stock price date	2026-10-28
Symbol	CHD
U.S. state	New Jersey
Website	https://www.churchdwight.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	29.81x
Average P/E ratio (10Y)	31.11x
Average P/E ratio (3Y)	37.05x
Average P/E ratio (5Y)	36.82x
Earnings yield	2.98%
EV/Earnings	36.29x
EV/EBIT	23.98x
EV/EBITDA	19.95x
EV/FCF	24.23x
EV/Sales	4.34x
FCF / EV yield	4.13%
FCF yield	4.49%
Forward EV/Sales	4.23x
Forward P/E	26.78x
Forward P/S	3.89x
Graham number	35.83976
Graham upside	-65.79%
Industry forward P/E	20.39x
Industry P/E	23.28x
Lynch fair value	$15.57
Lynch upside	-85.14%
P/(FCF - SBC) ratio	23.78x
P/(OCF - SBC) ratio	20.88x
P/B ratio	5.73x
P/E ratio	33.61x
P/FCF ratio	22.28x
P/OCF ratio	19.72x
P/S ratio	3.99x
PEG ratio	3.7x
Price/EBITDA ratio	18.34x
Sector forward P/E	21.33x
Sector P/E	28.29x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	18.09%
EBITDA margin	21.75%
Effective tax rate	21.83%
FCF margin	17.9%
Gross margin	45.56%
Operating margin	18.09%
Pretax margin	15.3%
Profit margin	11.96%
Profit per employee	$134,198
Profitable quarters	7
Profitable years	34
Revenue per employee	$1.1M
ROA	7.87%
ROA (5Y)	8.1%
ROCE	14.49%
ROE	17.04%
ROE (5Y)	18.24%
ROIC	14.01%
ROIC (5Y)	14.52%
SBC / revenue	1.13%
Tax / revenue	3.34%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	46.73%
EPS growth (Q)	8.97%
EPS growth (QoQ)	-6.59%
EPS growth 10Y	6.14%
EPS growth 3Y	19.75%
EPS growth 5Y	-0.6%
EPS growth quarters	2
EPS growth years	1
FCF growth	19.85%
FCF growth (Q)	23.33%
FCF growth (QoQ)	79.78%
FCF growth 3Y	8.19%
FCF growth 5Y	12.29%
Gross profit growth	4.04%
Gross profit growth (Q)	2.44%
Gross profit growth 3Y	5.56%
Gross profit growth 5Y	4.98%
Net income growth	41.81%
Net income growth (Q)	6.18%
Net income growth (QoQ)	-6.24%
Net income growth 3Y	18.57%
Net income growth 5Y	-1.55%
Net income growth quarters	1
Net income growth years	1
OCF growth	17.5%
OCF growth (Q)	24.26%
OCF growth (QoQ)	64.07%
OCF growth 10Y	6.78%
OCF growth 3Y	5.16%
OCF growth 5Y	11.36%
Operating income growth	-2.04%
Operating income growth (Q)	-11.61%
Operating income growth 3Y	2.33%
Operating income growth 5Y	3.79%
Revenue growth	2.69%
Revenue growth (Q)	1.57%
Revenue growth (QoQ)	4.13%
Revenue growth 10Y	6.05%
Revenue growth 3Y	3.38%
Revenue growth 5Y	4.3%
Revenue growth quarters	4
Revenue growth years	25

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-145.2M
Depreciation and amortization	$227.7M
EBIT	$1.1B
EBITDA	$1.4B
EPS	$3.11
FCF per share	$4.70
Financing cash flow	$-987.3M
Free cash flow	$1.1B
Free cash flow minus SBC	$1B
Gross profit	$2.8B
Income taxes	$208M
Investing cash flow	$-939.2M
Net borrowing	$49.9M
Net cash flow	$-668.4M
Net income	$744.8M
Operating cash flow minus SBC	$1.2B
Operating income	$1.1B
Revenue	$6.2B
Stock-based compensation	$70.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	5.01
Book value per share	$18.33
Debt / EBITDA	1.74
Debt / equity	0.56
Debt / FCF	2.18
Goodwill	$2.6B
Interest coverage	11.67
Long-term assets	$7.6B
Long-term liabilities	$3.4B
Net cash (debt)	$-2.2B
Net cash / market cap	-8.75%
Net debt / EBITDA	1.6
Net debt / equity	0.5
Net debt / FCF	1.95
Piotroski F-Score	6
Property, plant and equipment	$986M
Shareholders' equity	$4.3B
Tangible book value	$-2B
Tangible book value per share	$-8.62
Total assets	$9.1B
Total cash	$254.8M
Total debt	$2.4B
Total liabilities	$4.8B
WACC	6.57%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.7
Current assets	$1.5B
Current liabilities	$1.3B
Current ratio	1.15
Inventory turnover	5.54
Net working capital	$14.8M
Quick ratio	0.64
Working capital	$194.5M
Working capital turnover	10.25

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	3.01%
Dividend growth	4.17%
Dividend growth (10Y)	5.69%
Dividend growth (3Y)	4.08%
Dividend growth (5Y)	4.07%
Dividend growth years	30
Dividend payment date	2026-09-01
Dividend payment years	52
Dividend payout frequency	Quarterly
Dividend per share	$1.23
Dividend yield	1.17%
Ex-dividend date	2026-08-14
FCF payout ratio	26.16%
Last dividend	$0.31
Payout ratio	39.5%
Shareholder yield	4.19%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	119.23%
10Y return CAGR	9.57%
10Y total return	149.47%
150-day SMA	$97.44
15Y price change	369.66%
15Y return CAGR	12.46%
15Y total return	482.43%
1D price change	-0.35%
1M price change	8.57%
1M total return	8.57%
1W price change	-0.34%
1W total return	-0.34%
1Y price change	22.19%
1Y return CAGR	23.78%
1Y total return	23.77%
20-day SMA	$101.38
200-day SMA	$97.55
20Y price change	926.89%
20Y return CAGR	13.81%
20Y total return	1,229.25%
3M price change	6.02%
3M total return	6.34%
3Y price change	16.13%
3Y return CAGR	6.38%
3Y total return	20.38%
50-day SMA	$98.97
50-day SMA vs 200-day SMA	50over200
52-week high	$108.93
52-week high date	2026-10-22
52-week low	$81.33
52-week low date	2025-10-30
5Y price change	24.45%
5Y return CAGR	5.73%
5Y total return	32.1%
6M price change	9.69%
6M total return	10.38%
All-time high	$116.46
All-time high date	2025-03-10
All-time low	$0.81
All-time low date	1989-01-19
Average true range (ATR)	$1.94
Average volume	1.9M
Beta (1Y)	0.24
Beta (2Y)	0.1
Beta (5Y)	0.48
Change from 52-week high	-3.94%
Change from 52-week low	28.66%
Change from all-time high	-10.15%
Change from all-time low	12,778.77%
Change from open	0.58%
Day's gap	-0.92%
Dollar volume	$116.7M
High price	$105.06
Low price	$104.04
Monthly RSI	56.58
Open price	$104.04
Position in 52-week range	58.82%
Premarket change	-0.94%
Premarket close	$105.01
Premarket price	$104.02
Previous close	$105.01
Price vs 150-day SMA	7.39%
Price vs 20-day SMA	3.22%
Price vs 200-day SMA	7.27%
Price vs 50-day SMA	5.73%
Relative volume	0.59
RSI	60.86
Sharpe ratio	0.86
Sharpe ratio (3Y)	0.19
Sharpe ratio (5Y)	0.19
Sortino ratio	1.61
Sortino ratio (3Y)	0.54
Sortino ratio (5Y)	0.52
Volume	1.1M
Weekly RSI	60.84
YTD price change	24.79%
YTD total return	25.97%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	236.5M
Float percentage	99.69%
Shares change (QoQ)	0.04%
Shares change (YoY)	-3.01%
Shares held by insiders	0.21%
Shares held by institutions	93.8%
Shares outstanding	237.2M
Short % of float	5.14%
Short % of shares	5.12%
Short ratio	6.5 days

Deeper analysis on CHD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Quote this valuation with its source: Fair value, Potential value and the price at analysis.

Frequently asked questions

About this CHD report

What is the latest published CHD stock rating?

Church & Dwight Co., Inc. is shown with Reduce in the latest published report, analyzed 2026-10-08. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CHD analysis?

The full latest published report, analyzed 2026-10-08, lives at /stocks/CHD/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair value is used for CHD?

The latest published report analyzed 2026-10-08 gives CHD a fair value of USD 80 and a potential value of USD 89. These are dated research outputs, not live market prices; review the valuation assumptions, sensitivity analysis, and material risks before making a decision.

How often is the CHD page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-10-08). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

ReduceCHD · Fair value $80.3-18.0%

Read full analysis →

Church & Dwight Co., Inc. (CHD)

Our latest published analysis: CHD rated Reduce

Price

Financial snapshot

Fair-value bridge

Latest news · CHD

Valuation

Profitability

Balance sheet

Trading

Base and Bull scenarios

Sensitivity: Ke × terminal growth

Scorecard

Next earnings

Sector percentile context

All CHD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CHD

Frequently asked questions

Ratinggeschiedenis

Category	Score	Reading
Valuation	3.0
Management	8.5
Balance Sheet	6.0
Profitability	6.5
Revenue Growth	4.5
Risk Assessment	7.5
Competitive Moat	7.5
Earnings Quality	8.0
Capital Efficiency	6.5